MEDICAMEN BIOTECH
Back to Income Statement
|
MEDICAMEN BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹15 Cr | ₹15 Cr | ₹1,212,944 Cr | ₹13 Cr | ₹12 Cr |
What is the latest Consolidated Net Profit of MEDICAMEN BIOTECH ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹15 Cr |
Mar2023 | ₹15 Cr |
Mar2022 | ₹1,212,944 Cr |
Mar2021 | ₹13 Cr |
Mar2020 | ₹12 Cr |
How is Consolidated Net Profit of MEDICAMEN BIOTECH Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹15 Cr | -1.13 | |
Mar2023 | ₹15 Cr | -100.00 | |
Mar2022 | ₹1,212,944 Cr | 9,125,955.15 | |
Mar2021 | ₹13 Cr | 10.52 | |
Mar2020 | ₹12 Cr | - |
Compare Consolidated Net Profit of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹492.3 Cr | 2.2% | -9.2% | -13.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,419.0 Cr | -0.2% | -2.3% | -7.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | -1.7% | -8.8% | 27.2% | Stock Analytics | |
CIPLA | ₹128,659.0 Cr | 1.9% | 8.7% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,448.0 Cr | 0.7% | 4.1% | 8.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,539.0 Cr | 1.4% | 2.9% | -10.6% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | 2.2% |
-9.2% |
-13.1% |
SENSEX | 1.8% |
-0.2% |
2% |
You may also like the below Video Courses